Leading The Global Cannabis Revolution
Clever Leaves CEO, Kyle Detwiler, and his team will discuss their operations, strategic insights, exciting new partnerships, and the opportunities for you to participate in this fast growing industry.
Date & Time:
June 9, 10:00 AM CST
Webinar: Details provided upon RSVP approval
About the Event:
In 2018, the global Cannabis industry was worth $10b USD and it’s just getting started. By 2026 experts predict nearly a 10x growth with a value of more than $97b by 2026. Cleaver Leaves is a leader in the cannabis industry and one of the few true global players in the market today.
With established interests and operations in Germany, Portugal, Canada, the United States, and South America, Clever Leaves operates in all segments of the market.
- Their cultivation field in Portugal is the second largest production land plot in Europe.
- They are just one of two companies licensed to provide pharmaceutical grade cannabinoid extracts in Germany.
- They have created best-in-class consumer CBD brands in markets around the world.
- Their large scale cultivation and extraction facilities have allowed them to become a major wholesale supplier of cannabinoids to companies around the world.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.